MiMedx Group negotiates $5 million private placement of common shares

Deal proceeds to fund marketing initiatives, development of products

By Devika Patel

Knoxville, Tenn., Sept. 29 - MiMedx Group, Inc. said it plans a $5 million private placement of stock.

Proceeds will be used to provide working capital for the company's expanded global sales and marketing initiatives for its HydroFix Vaso Shield and HydroFix Spine Shield products and for development activities related to advancing the company's other HydroFix technology platform products and its multiple CollaFix technology platform products.

MiMedx is a Destin, Fla., developer of biomaterial-based products for use in the musculoskeletal specialties.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.